PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • IPM receives multi-year award from UK government to advance technologies for women's HIV

    The nonprofit International Partnership for Microbicides (IPM) announced today that it has received a £12 million (US$15.6 million) award over four years from the United Kingdom government through the Department for International Development to advance promising HIV and multipurpose prevention products that women could use to protect their sexual and reproductive health.

    20 July 2017 | Eurekalert Medicine & Health
  • Pre-exposure prophylaxis (PrEP) soon in Ukraine

    The clients of the “ALLIANCE.GLOBAL”, PO will be the first in Ukraine to be able to use free pre-exposure prophylaxis of HIV infection (PrEP) already in 2017.

    20 July 2017 | PO Alliance Global
  • Wales: Trial of 'game-changing' HIV drug gets underway

    Trials of a drug to protect people against contracting HIV get underway this week in Wales. The drug, known as PrEP (pre-exposure prophylaxis) can be taken 'on demand' in order to protect against infection.

    19 July 2017 | ITV News
  • The 2017 Pipeline Report

    Treatment Action Group (TAG) announces the launch of its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

    19 July 2017 | Treatment Action Group
  • PrEPARED in Wales

    Information on getting PrEP from the NHS in Wales.

    18 July 2017 | Frisky Wales
  • Labour pledges to fund anti-HIV meds

    The Labour Party is accusing the government of dragging its heels on funding a drug which could prevent a large percentage of HIV transmissions.

    17 July 2017 | Radio New Zealand
  • Drug reducing risk of HIV transmission in healthy people okayed

    A drug named Truvada that can reduce the risk of contracting HIV from sexual contact by more than 90%, and by more than 70% for people who inject drugs, has been approved by the Health Ministry for marketing in Israel.

    17 July 2017 | The Jerusalem Post
  • PrEP conspiracies and stigma are killing us

    Two studies have shown that the people who have the highest risk of acquiring HIV are the ones most likely prevented from taking PrEP by beliefs about what using the HIV prevention drug might say about them, or whether they are being used through PrEP. Stigma continues to interfere in our health care and this country’s history of medical racism casts a long shadow.

    15 July 2017 | The Advocate
  • IPM's dapivirine vaginal ring now under review by European Medicines Agency

    The nonprofit International Partnership for Microbicides (IPM) is pleased to announce that its application for the monthly dapivirine vaginal ring, designed to reduce the risk of HIV-1 infection via vaginal intercourse in HIV-negative women in combination with safer sex practices, has been validated and is now under review by the European Medicines Agency (EMA).

    14 July 2017 | Eurekalert Medicine & Health
  • An easy-to-read explanation of using antibodies for PrEP

    Although the research on antibodies for HIV prevention, treatment and cure can be confusing, it’s an exciting area of inquiry. Here, you’ll find an easy-to-read primer about HIV prevention with antibodies, and what you can be on the look-out for if new HIV prevention options (hopefully) start moving from the laboratory into the real world.

    14 July 2017 | BETA blog
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.